Long-term outcomes of endovascular embolization and stereotactic radiosurgery as the first-line treatment for ruptured arteriovenous malformations: a propensity score-matched analysis using nationwide multicenter prospective registry data

医学 倾向得分匹配 放射外科 危险系数 置信区间 优势比 子群分析 临床终点 冲程(发动机) 栓塞 前瞻性队列研究 外科 随机对照试验 内科学 放射治疗 机械工程 工程类
作者
Yú Chen,Chengzhuo Wang,Heze Han,Li Ma,Ruinan Li,Zhipeng Li,Haibin Zhang,Kexin Yuan,Anqi Li,Qinghui Zhu,Yingying Su,Dezhi Gao,Hengwei Jin,Youxiang Li,Shibin Sun,Yuanli Zhao,Xiaolin Chen,Jizong Zhao
出处
期刊:International Journal of Surgery [Wolters Kluwer]
卷期号:111 (8): 5182-5191
标识
DOI:10.1097/js9.0000000000002546
摘要

Background: This study aimed to evaluate and compare the risk-benefit profiles of endovascular embolization (EM) and stereotactic radiosurgery (SRS) as first-line therapeutic strategies for the management of ruptured arteriovenous malformations (AVMs). Materials and methods: We included patients with ruptured AVMs who underwent EM or SRS as the first-line treatments from a nationwide prospective multicenter registry (the MATCH study) in China. Propensity score matching was employed to balance baseline characteristics between the EM and SRS groups. The primary outcomes were long-term hemorrhagic stroke or death, while secondary outcomes included long-term obliteration rates and neurological status. Subgroup analyses and sensitivity analyses using alternative study designs were conducted to ensure the robustness and consistency of the findings. Result: Of 3909 consecutive AVMs in the registry from 2011.08 to 2021.12, 1067 patients were eligible. After matching, 640 AVMs remained for the final analysis. The mean follow-up duration was 5.27 years. In terms of primary outcomes, SRS was associated with a lower risk of hemorrhagic stroke or death (hazard ratio [HR] 0.36, 95% confidence interval [CI] 0.23 to 0.58). Regarding the secondary outcomes, SRS was observed to have a significant advantage in long-term obliteration (odds ratio [OR] 7.89, 95% CI 5.15 to 12.11), and the incidence was significantly lower in the SRS group than in the EM group for the disabling neurological deficits (OR, 0.42, 95% CI, 0.25 to 0.70). Results of subgroup analyses and sensitivity analyses were consistent in the trend but with slightly varied powers. Conclusion: This study suggests that SRS can be more effective than EM in preventing future hemorrhagic stroke or death, achieving complete obliteration, and reducing long-term neurological disability.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜的应助被科研通管家采纳,获得10
刚刚
null的应助被科研通管家采纳,获得10
刚刚
ZoeyD完成签到,获得积分10
1秒前
1秒前
1秒前
李健的应助被科研通管家采纳,获得10
1秒前
1秒前
爆米花的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
DW的应助被科研通管家采纳,获得10
1秒前
大个的应助被科研通管家采纳,获得10
1秒前
烟花的应助被科研通管家采纳,获得10
1秒前
脑洞疼的应助被科研通管家采纳,获得10
2秒前
小菜发布了新的文献求助10
2秒前
Akim的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
打打的应助被科研通管家采纳,获得10
2秒前
null的应助被科研通管家采纳,获得10
2秒前
李健的小迷弟的应助被YA采纳,获得10
2秒前
小思雅完成签到 ,获得积分10
3秒前
lmg发布了新的文献求助10
3秒前
4秒前
4秒前
molihuakai的应助被Maestro_S采纳,获得10
6秒前
ll关注了科研通微信公众号
6秒前
大个的应助被Charming采纳,获得10
7秒前
8秒前
小马甲的应助被DS采纳,获得10
8秒前
欧阳卓斌完成签到 ,获得积分10
9秒前
郑睿涛发布了新的文献求助10
10秒前
10秒前
11秒前
TaoJ的应助被牧百川采纳,获得10
11秒前
隐形曼青的应助被彼岸采纳,获得10
11秒前
小fool发布了新的文献求助10
11秒前
狗熊岭在逃翠花完成签到,获得积分10
12秒前
平常香发布了新的文献求助10
12秒前
领导范儿的应助被阿阳啊采纳,获得10
13秒前
gxy完成签到 ,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183739
求助须知:如何正确求助?哪些是违规求助? 9572996
关于积分的说明 21828615
捐赠科研通 7780904
什么是DOI,文献DOI怎么找? 3434101
关于科研通互助平台的介绍 2558294
邀请新用户注册赠送积分活动 2480564